Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma

NCT04512833 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT04512833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04512833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 12, 2020
Completion date
August 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma